Rosalind Advisors, Inc.

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1622627 TORONTO, A6

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$34,271,010

+$16,385,574 QoQ

Shares Held

3,188,001

+9.6% QoQ

Ownership

9.09%

of shares outstanding

% of Portfolio

12.84%

of 13F equity value

Holder Rank

of 105 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rosalind Advisors, Inc. holds $173,098,579 across 19 Biotechnology names. FENC ranks #1 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FENC	Fennec Pharmaceuticals Inc. This page	3,188,001	$34,271,010
2	SVRA	Savara Inc	3,178,121	$19,577,225
3	VSTM	Verastem, Inc.	3,986,509	$15,228,464
4	XFOR	X4 Pharmaceuticals, Inc	3,214,766	$15,012,957
5	EYPT	EyePoint, Inc.	988,230	$14,131,689
6	HELP	Cybin Inc.	1,956,814	$12,934,540
7	VOR	Vor Biopharma Inc.	648,600	$11,940,726
8	PCVX	Vaxcyte, Inc.	200,000	$11,626,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$35,704,329	3,321,333	+9.2%	Shares	Sole	2026-08-13
2026-06-30	$34,271,010	3,188,001	+9.6%	Shares	Sole	2026-08-14
2026-03-31	$18,705,427	3,041,533	+46.5%	Shares	Sole	2026-05-14
2026-03-31	$17,885,436	2,908,201	+11.3%	Shares	Sole	2026-05-14
2025-12-31	$20,124,011	2,613,508	+25.8%	Shares	Sole	2026-02-12
2025-09-30	$19,439,222	2,076,840	+1.5%	Shares	Sole	2025-11-13
2025-09-30	$19,439,222	2,076,840	—	Shares	Sole	2025-11-13
2025-06-30	$16,978,845	2,045,644	+14.7%	Shares	Sole	2025-08-14
2025-03-31	$10,857,519	1,782,844	+41.5%	Shares	Sole	2025-05-14
2024-12-31	$7,962,416	1,259,876	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.